Fundraising FoxSCI Ventures — Full Portfolio
17 tracked investments · listed companies and verified rows first
Groww is an Indian investing platform offering stock broking and mutual fund distribution to retail investors in India.
ConsumerFintechBengaluru, IN
Lalit Keshre(CEO)inIshan Bansal(Founder)inHarsh Jain(COO)inNeeraj Singh(Founder)in
BoardAnu Hariharan(Director)inAshish Agrawal(Nominee Director)
Co-investorsAlkeon InnovationEnsemble VCFrialeICONIQInsignia Ventures PartnersK50 Ventures+11 more
NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair.
BiotechDeep TechHealthtechMedical Devices
Harold Punnett(Co-founder)inJerry Silver(Co-founder)William Adams(Executive Officer)Paul Brennan(Director, Executive Officer)inDaniel Mikol(Executive Officer)inAdam Rogersin
Co-investorsCWRU Technology Ventures
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
Bik.ai builds an AI-powered CRM platform for ecommerce brands to manage marketing, customer support, and sales through conversational AI agents.
AI & Machine LearningE-commerceEnterprise SoftwareSaaSSan Francisco, US
Sonakshi Nathani(Founder)inAshutosh Singla(Founder)inASHUTOSH SINGLA(Founder)inAnushka Saha(Recruiter)Harika Bondili(Recruiter)
Co-investorsPioneerY CombinatorMantis CapitalPeak XV PartnersVenture Investment AssociatesVentureSouq
Cyllene Therapeutics is a biotechnology company developing "pinpoint gene therapy" using a non-replicative HSV-1 based vector platform to deliver disease-modifying transgenes for peripheral nervous system disorders.
BiotechDeep TechDigital HealthParis, FR
Philippe Chambon MD, PhD(Founder)inPhilippe Chambon(Founder, Chairman & CEO)Alberto Epstein(Founder & CSO)Cornelia Haag-Molkenteller(CMO)Samuel Salot(COO)Marc Grasso(CFO)
Co-investorsBpifranceM VenturesAndera Partners
Drip Capital is a trade finance and B2B commerce company that provides credit assessment and automated transaction workflows to help small and midsize businesses conduct cross-border trade.
FintechLogistics & Supply ChainMH, IN
Pushkar Mukewar(CEO)inNeil Kothari(CEO)Yash Kothari(New Business Development)inNaqiyah Sohagpurwalla(Recruiter)Chanchal Singh(HR Lead)
Co-investorsAccelY CombinatorSequoia CapitalSumitomo Mitsui Banking CorporationTD BankBetter Tomorrow Ventures+20 more
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence.
AI & Machine LearningBiotechDigital HealthHealthtechCambridge, GB
Tim Guilliams(Founder)inDr David Brown(Co-Founder and Board member)inDavid J. Brown(Founder)in
Co-investorsAmadeus Capital PartnersAurum Venture PartnersBalderton CapitalCambridge Angels groupDaniel GutenbergGlobal Brain+4 more
Khatabook offers a mobile app that lets business owners replace paper ledgers with digital bookkeeping, recording credit (Jama) and debit (Udhar) transactions for their customers.
FintechSaaSBengaluru, IN
Ravish Naresh(CEO)inAshish Sonone(Founder)Gaurav Lahoti(Founder)Jaideep Poonia(Founder)Rishabh Gupta(Founder)Vaibhav Kalpe(Founder)
Co-investorsAlkeon InnovationAlpha Wave GlobalAngel Collective Opportunity FundB Capital GroupB4 CapitalBetter Capital+30 more
.jpeg){kind=logo}
Precision Neuroscience develops a minimally invasive, high-bandwidth brain-computer interface, including its Layer 7 cortical interface, initially aimed at helping people with paralysis control digital devices and robotics using their thoughts.
Deep TechDigital HealthHealthtechMedical DevicesNew York, US
Benjamin Rapoport(President, Chief Science Officer)inMichael Mager(Chief Executive Officer)inCraig Mermel(President and Chief Product Officer)inMIchael Kaswan(Chief Financial Officer)Konstantinos Alataris(President)inBenjamin Rapoport Michael Mager(Founder)
Co-investorsAlumni VenturesB Capital GroupB4 CapitalBasecamp FundDolby Family VenturesDraper Associates+5 more
ViaNautis develops targeted polyNaut nanovesicle (tPNV) delivery technology to advance cell and gene therapies and genetic medicines.
BiotechDeep TechMedical DevicesCambridge, GB
Co-investorsCambridge Angels groupOxford Investment Opportunity Network (OION)4BIO CapitalOrigin CapitalUCB Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AugmentalAxonisCraighospitalEgOnwardOnward MedicalSania Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.